@Guts I hear what you are saying, however conversely we also benefit from the share price, revenue and build from ASP Isotopes.
I have only just started to evaluate the true potential they offer and I probably do not have full appreciation of the risks and rewards at this stage.
On face value though it appears to be in an extremely good position commencing production of highly valued Isotopes for medical and electronic purposes and the commencement of producing HALEU for TerraPower. RLT shareholders should receive shares in QLE, a spinoff which will manage the HALEU business.
If the deal goes through, ASPI will have 90 million shares on issue. The proposed EBITDA of both entities, plus QLE should still provide a decent dividend.
I’ve been told that they are drilling at the moment but it hasn’t been confirmed. I still have concerns relating to finance and there are still questions relating to ASPI (whether the technology exists or does what they espouse) but for me it may be worth holding considering the share price of ASPI is flirting with what RLT owes me.
(20min delay)